Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol alone versus propofol plus cisatracurium for laryngeal mask airway insertion
IRCT20200108046052N1Phase 2Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of propofol and cisatracurium (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Hemodynamic status and Laryngeal mask airway insertion conditions. Started Feb 2020; status: completed.
02
Drugs
propofolcisatracurium
Beyond the preview
Go deeper on IRCT20200108046052N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200108046052N1.